(Press-News.org) Ghent, 12 February 2026 – VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body. In a study published in Nature Neuroscience, the scientists also reveal a new pathway by which the immune system can impact the brain.
Prof. Roosmarijn Vandenbroucke (VIB–UGent Center for Inflammation Research): “These findings reveal how vulnerable and protectable the brain is, opening new perspectives for more targeted interventions in brain disorders.”
The brain is protected from the rest of the body by multiple barriers that maintain a stable, tightly regulated environment and defend it against harmful substances and pathogens. The most well-known of these barriers is the blood-brain barrier but another critical interface is the choroid plexus, a small structure found within the brain's fluid-filled spaces, which produces cerebrospinal fluid. However, despite its importance, scientists know surprisingly little about the choroid plexus’ detailed cellular structure and how it protects the brain.
A new line of defense for the brain
Researchers from the Vandenbroucke lab at the VIB-UGent Center for Inflammation Research set out to unravel this puzzle. Using advanced gene sequencing techniques and high-resolution microscopy, the research team identified a unique population of cells located at the base of the choroid plexus that they coined the base barrier cells. These cells are linked together by tight junctions, molecular rivets that effectively form a seal. This barrier provides a functional compartmentalization of the choroid plexus, the brain, and the cerebrospinal fluid.
“We’ve uncovered a new line of defense for the brain,” explains Prof. Vandenbroucke (VIB-UGent). “These cells form a smart, dynamic gate at a location we hadn’t fully appreciated. It’s exciting because it not only answers a fundamental anatomical question but also gives us a new target for understanding brain disease.”
A dynamic barrier vulnerable to disease
The team’s work shows that this barrier is not static. Under healthy conditions, it effectively limits the movement of even small molecules from the choroid plexus’ blood-rich core into the surrounding cerebrospinal fluid and brain tissue. However, during systemic inflammation, such as that caused by a severe infection, the barrier becomes compromised.
“We see that the base barrier cells become vulnerable during inflammation, potentially allowing harmful substances and cells to enter the central nervous system,” explains Dr. Daan Verhaege, who completed his PhD in the Vandenbroucke lab.
The base barrier cells emerge early in development and are maintained throughout life. Importantly, the researchers confirmed that these cells are present not only in mouse brains but also in human brains, making the findings highly relevant to human health and disease.
This discovery opens new avenues for investigating neurological conditions and neuroinflammation, and may lead to novel therapeutic strategies aimed at strengthening this gatekeeper barrier.
END
Scientists discover new gatekeeper cell in the brain
2026-02-12
ELSE PRESS RELEASES FROM THIS DATE:
High blood pressure: trained laypeople improve healthcare in rural Africa
2026-02-12
In rural regions of Africa, high blood pressure often goes untreated because health centres are far away and there is a shortage of health professionals. A study in Lesotho shows that, with the help of a tablet app, villagers who have received training achieve better blood pressure control in their village community compared to normal treatment in healthcare facilities. The results provide the first robust data for an approach that could significantly improve access to blood pressure treatment in underserved regions. ...
Pitt research reveals protective key that may curb insulin-resistance and prevent diabetes
2026-02-12
Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes – by boosting a special type of “good” immune cell in fat tissue.
Announced today in Nature Communications, the preclinical findings pave the path to develop a medication to treat and prevent type 2 diabetes, potentially replacing or supplementing GLP-1 weight maintenance drugs that lose effectiveness over time.
“One-third of our population is obese or overweight – over the next decade or so, ...
Queen Mary research results in changes to NHS guidelines
2026-02-12
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change to NHS treatment guidelines. For people with the condition, this means fewer toxic side effects and a better quality of life during treatment.
Until recently, people with advanced bladder cancer routinely received between four to six cycles of intensive chemotherapy, followed by avelumab, a type of immunotherapy, as standard NHS care. ...
Sleep‑aligned fasting improves key heart and blood‑sugar markers
2026-02-12
Nighttime blood pressure dipped by 3.5%, heart rate dipped by 5% compared to controls
Given high adherence rate (nearly 90%), novel approach may be a more accessible non-pharmacological strategy for improving cardiometabolic health
‘It’s not only how much and what you eat, but also when you eat relative to sleep that is important’
CHICAGO --- A new Northwestern Medicine study has personalized overnight fasting by aligning it with individuals’ circadian sleep-wake rhythm — an important regulator of cardiovascular and metabolic function — without changing their caloric ...
Releasing pollack at depth could benefit their long-term survival, study suggests
2026-02-12
During 2026, new legislation – the result of an agreement between the UK Government and the European Union – is planned to come into force for recreational pollack fishing that limits catches to three fish per angler per day.
It will result in more fish being released after they are caught, but new research has suggested changing how that release happens could have a marked difference on the fisheries’ long-term sustainability.
Specifically, it suggests that releasing pollack closer to the depths they are normally caught could improve their chances of survival ...
Addictive digital habits in early adolescence linked to mental health struggles, study finds
2026-02-12
February 12, 2026 - New research following US adolescents ages 11–12 shows that problematic use of mobile phones, social media, and video games was associated with higher risks of mental health problems, sleep disturbance, and suicidal behaviors one year later. The study in the American Journal of Preventive Medicine, published by Elsevier, reveals that the links between problematic screen use and mental health are stronger than those previously reported for overall screen time and highlights the risks of addictive use.
Screen use increases rapidly during early adolescence, ...
As tropical fish move north, UT San Antonio researcher tracks climate threats to Texas waterways
2026-02-12
The National Science Foundation has awarded a UT San Antonio assistant professor of biology, health and the environment the distinguished Faculty Early Career Development Program (CAREER) award.
The assistant professor, Matthew Troia, will use the award to investigate how climate change and urbanization are affecting freshwater ecosystems by enabling exotic tropical fish species to expand northward.
“We hope our research will provide a deeper understanding of how biodiversity responds to increasing human impacts on the environment,” Troia said. “Our goal is to ...
Rich medieval Danes bought graves ‘closer to God’ despite leprosy stigma, archaeologists find
2026-02-12
Medieval Christians in Denmark showed off their wealth in death by buying prestigious graves: the closer to the church, the higher the price. Researchers used these gravesites to investigate social exclusion based on illness, by studying whether people with leprosy — a highly stigmatized disease culturally associated with sin — or tuberculosis were kept out of the higher-status areas. Unexpectedly, they found that people who were ill with stigmatized diseases were buried just as prominently as their peers.
“When we started this ...
Brexpiprazole as an adjunct therapy for cognitive dysfunction in schizophrenia
2026-02-12
Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients. However, no effective treatment has yet been established for it. Now, researchers have investigated the effect of adding brexpiprazole on cognitive function in patients with schizophrenia. The findings revealed that patients with schizophrenia receiving adjunctive brexpiprazole showed a meaningful improvement in information processing speed, without worsening psychiatric symptoms.
Schizophrenia ...
Applications of endovascular brain–computer interface in patients with Alzheimer's disease
2026-02-12
Background
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment with an insidious and irreversible pathological process. As the global population ages, AD imposes a heavy burden on families and society: one new case is diagnosed every 3 seconds worldwide. Advanced-stage patients lose full self-care ability, and the associated medical and nursing costs account for over 1.3% of the global GDP.
Current clinical treatments mainly focus on symptomatic relief: cholinesterase inhibitors and the N-methyl-D-aspartate ...